COMPASS PATHWAYS PLC -
5,3000
07-ноября-24 15:59:59
15 мин. задержка
Акции
+0,5700
+12,05%
Сегодняшний диапазон
4,7500 - 5,4700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
26 май 2023 16:00:00 Источник Nasdaq GlobeNewswire
-
26 май 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights
11 май 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023
03 май 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
American Medical Association to Issue First New Code for Psychedelic Therapies
02 май 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference
10 апр 2023 10:10:13 Источник Nasdaq GlobeNewswire
-
02 мар 2023 10:23:22 Источник Nasdaq GlobeNewswire
-
24 фев 2023 12:01:00 Источник Nasdaq GlobeNewswire
-
08 дек 2022 04:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference
28 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights
03 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
03 ноя 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022
26 окт 2022 16:00:00 Источник Nasdaq GlobeNewswire
-
12 окт 2022 11:00:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to Hold Virtual Capital Market Day on 12 October 2022
04 окт 2022 09:05:40 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit
19 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways to participate in three upcoming investor events
01 сен 2022 08:06:21 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
04 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
02 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa
28 июл 2022 04:00:00 Источник Nasdaq GlobeNewswire